Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Traffic & App Usage Insights

Discover domain traffic and app usage trends for companies and their competitors.

Last Close
Oct 04 04:00PM ET
2.69
Dollar change
-0.05
Percentage change
-1.74
%
Index- P/E- EPS (ttm)-0.80 Insider Own- Shs Outstand5.70M Perf Week-1.82%
Market Cap15.33M Forward P/E- EPS next Y-0.01 Insider Trans- Shs Float3.25M Perf Month1.13%
Income-4.55M PEG- EPS next Q-0.01 Inst Own0.20% Short Float0.18% Perf Quarter33.83%
Sales3.21M P/S4.78 EPS this Y-33.33% Inst Trans-59.50% Short Ratio0.96 Perf Half Y-0.74%
Book/sh1.49 P/B1.81 EPS next Y50.00% ROA-36.40% Short Interest0.01M Perf Year37.95%
Cash/sh1.37 P/C1.97 EPS next 5Y- ROE-42.27% 52W Range1.48 - 5.96 Perf YTD43.47%
Dividend Est.- P/FCF- EPS past 5Y2.81% ROI-53.09% 52W High-54.87% Beta-
Dividend TTM- Quick Ratio4.87 Sales past 5Y119.81% Gross Margin68.06% 52W Low81.63% ATR (14)0.16
Dividend Ex-Date- Current Ratio5.46 EPS Y/Y TTM-78.77% Oper. Margin-175.97% RSI (14)52.01 Volatility4.47% 6.26%
Employees- Debt/Eq0.01 Sales Y/Y TTM164.30% Profit Margin-141.71% Recom1.00 Target Price5.00
Option/ShortNo / Yes LT Debt/Eq0.01 EPS Q/Q-161.79% Payout- Rel Volume0.73 Prev Close2.74
Sales Surprise- EPS Surprise- Sales Q/Q103.24% EarningsAug 30 Avg Volume6.20K Price2.69
SMA201.04% SMA503.67% SMA20014.66% Trades Volume4,535 Change-1.74%
Oct-04-24 06:30AM
Sep-25-24 07:00AM
Sep-24-24 07:00AM
Sep-05-24 11:54AM
Aug-21-24 07:00AM
07:00AM Loading…
Aug-20-24 07:00AM
Aug-16-24 06:00AM
Aug-15-24 06:14PM
Aug-07-24 06:00AM
Jul-17-24 07:00AM
Jul-15-24 08:00AM
Jul-02-24 06:00AM
Jun-12-24 07:00AM
Jun-11-24 07:00AM
Jun-05-24 06:00AM
06:00AM Loading…
May-31-24 06:00AM
06:00AM
May-08-24 07:50AM
May-07-24 07:00AM
06:00AM
May-03-24 06:00AM
Apr-15-24 06:00AM
Apr-10-24 06:00AM
Mar-07-24 06:00AM
Feb-21-24 06:00AM
Feb-13-24 06:00AM
Feb-08-24 06:00AM
Jan-16-24 06:00AM
Dec-22-23 06:00AM
Dec-04-23 06:00AM
06:33AM Loading…
Nov-28-23 06:33AM
Nov-13-23 06:00PM
Oct-30-23 07:21AM
Oct-18-23 06:00AM
Oct-11-23 06:00AM
Sep-18-23 07:30AM
Sep-14-23 01:30PM
Sep-13-23 06:00AM
Sep-11-23 06:00AM
Aug-23-23 08:30AM
Aug-14-23 06:00AM
Jul-26-23 02:45PM
Jul-25-23 06:00AM
Jul-24-23 06:00AM
Jul-19-23 08:30AM
Jul-11-23 06:00AM
Jul-05-23 06:00AM
Jun-30-23 06:00AM
Jun-22-23 06:00AM
May-30-23 06:00AM
May-16-23 07:30AM
May-08-23 01:11PM
06:00AM
May-02-23 06:00AM
Apr-19-23 06:00AM
Apr-11-23 06:00AM
Apr-06-23 06:00AM
Feb-15-23 06:00AM
Jan-25-23 06:00AM
Jan-18-23 05:00AM
Jan-17-23 07:10AM
Dec-23-22 06:00AM
Dec-05-22 06:00AM
Nov-16-22 07:00AM
Oct-26-22 06:00AM
Oct-13-22 10:28AM
06:00AM
Oct-04-22 06:00AM
Aug-29-22 07:00AM
Aug-19-22 07:23AM
06:00AM
Jul-26-22 07:07AM
06:00AM
Jul-11-22 06:00AM
Jul-07-22 06:00AM
May-11-22 06:00AM
May-09-22 06:00AM
May-05-22 08:22PM
Apr-27-22 06:00AM
Apr-19-22 07:33AM
Mar-25-22 05:21AM
Mar-16-22 09:30AM
Jan-17-22 06:00AM
Jan-13-22 06:00AM
Jan-12-22 02:58PM
07:28AM
06:34AM
06:00AM
04:59AM
Nov-15-21 06:00AM
Nov-10-21 06:00AM
Oct-08-21 08:10AM
07:34AM
06:00AM
Sep-24-21 08:40PM
Sep-23-21 11:00PM
09:00AM
May-13-21 06:00AM
Mar-02-21 11:40AM
Jan-11-21 06:00AM
Immuron Ltd. is a biopharmaceutical company, which focuses on the development and commercialization of a novel class of specifically targeted polyclonal antibodies. Its proprietary technology is based on polyclonal immunoglobulins derived from engineered hyper-immune bovine colostrum. This technology can be used to target viruses or bacteria and neutralize the toxins they produce on mucosal surfaces. It operates through the Research and Development, and Hyperimmune Products segments. The Research and Development segment includes projects performed in Australia and United States. The Hyperimmune Products segment is composed of Travelan, and Protectyn activities which occur in Australia, United States, and rest of the world. The company was founded on January 13, 1994, and is headquartered in Carlton, Australia.